These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
554 related items for PubMed ID: 24065447
1. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Ali ZA, Roleder T, Narula J, Mohanty BD, Baber U, Kovacic JC, Mintz GS, Otsuka F, Pan S, Virmani R, Sharma SK, Moreno P, Kini AS. Circ Cardiovasc Interv; 2013 Oct 01; 6(5):507-17. PubMed ID: 24065447 [Abstract] [Full Text] [Related]
2. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan Lee C, Park SW, Park SJ. Circulation; 2011 Jun 28; 123(25):2954-63. PubMed ID: 21646494 [Abstract] [Full Text] [Related]
5. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, Regar E. JACC Cardiovasc Interv; 2009 May 28; 2(5):445-52. PubMed ID: 19463469 [Abstract] [Full Text] [Related]
6. Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography. Porto I, Di Vito L, Burzotta F, Niccoli G, Trani C, Leone AM, Biasucci LM, Vergallo R, Limbruno U, Crea F. Circ Cardiovasc Interv; 2012 Feb 01; 5(1):89-96, S1-6. PubMed ID: 22298799 [Abstract] [Full Text] [Related]
7. Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome study. Austin D, Oldroyd KG, McConnachie A, Slack R, Eteiba H, Flapan AD, Jennings KP, Northcote RJ, Pell AC, Starkey IR, Pell JP. Circ Cardiovasc Interv; 2008 Aug 01; 1(1):45-52. PubMed ID: 20031654 [Abstract] [Full Text] [Related]
9. In vivo virtual histology intravascular ultrasound comparison of neointimal hyperplasia within drug-eluting- versus bare metal stents. Wakabayashi K, Mintz G, Delhaye C, Choi YJ, Doh JH, Ben-Dor I, Gaglia M, Pakala R, Suddath W, Satler L, Kent K, Pichard A, Weissman N, Waksman R. J Invasive Cardiol; 2011 Jul 01; 23(7):262-8. PubMed ID: 21725119 [Abstract] [Full Text] [Related]
11. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis. Nakamura D, Attizzani GF, Toma C, Sheth T, Wang W, Soud M, Aoun R, Tummala R, Leygerman M, Fares A, Mehanna E, Nishino S, Fung A, Costa MA, Bezerra HG. Circ Cardiovasc Interv; 2016 Sep 01; 9(9):. PubMed ID: 27582113 [Abstract] [Full Text] [Related]
16. Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS). Jensen LO, Vikman S, Antonsen L, Kosonen P, Niemelä M, Christiansen EH, Kervinen K, Erglis A, Harnek J, Kumsars I, Thuesen L, Niemelä K. Cardiovasc Revasc Med; 2017 Dec 01; 18(8):577-582. PubMed ID: 29066343 [Abstract] [Full Text] [Related]
20. OCT analysis in patients with very late stent thrombosis. Kang SJ, Lee CW, Song H, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Mintz GS, Park SW, Park SJ. JACC Cardiovasc Imaging; 2013 Jun 01; 6(6):695-703. PubMed ID: 23643282 [Abstract] [Full Text] [Related] Page: [Next] [New Search]